Skip to main content

Table 3 Peripartum blood analysis in pregnant women with or without active disease at delivery

From: Obstetric and perinatal outcomes in parturients with active SARS-CoV-2 infection during labor and delivery: a retrospective cohort study

Blood parameters

COVID-19- recovered patients

COVID-19- active patients

p-value

N = 92

N = 84

WBC (K/micL),a highest measured

12.35 (7.33–20.4)

10.2 (5.69–21.7)

0.0064

WBC ≥ 15 K/micL

10 (17.85%)

8 (9.52%)

0.02

Lymphocytes (K/micL),a lowest measured

1.7 (0.6–3.7)

1.3 (0.3–3.6)

 < 0.0001

Lymphocytes < 1 K/micL

2 (3.5%)

18 (21.43%)

0.003

Hemoglobin (g/dL), lowest measured

11.4 (6.8–14.1)

10.9 (6.2–13.6)

0.09

Hemoglobin < 10 g/dL

15 (26.78%)

23 (27.38%)

1

Platelets (K/micL),a lowest measured

199.5 (85–356)

161 (27–352)

 < 0.001

Platelets < 150 K/micL

10 (17.85%)

29 (34.52%)

0.03

INR, highest measuredb

0.95 (0.9–0.99)

0.97 (0.86–1.23)

0.08

INR > 1.1

0 (0%)

6 (7.14%)

0.57

Fibrinogen (mg/dL), lowest measuredc

640.5 (193–833)

587 (156–837)

0.062

Fibrinogen < 200 mg/dL

1 (5.55%)

2 (2.77%)

0.52

AST (U/L), highest measuredd

30 (15–143)

26 (15–178)

0.96

AST > 31 mg/dl

2 (33.33%)

16 (37.20%)

0.85

ALT (U/L), highest measurede

17 (7–375)

18 (6–111)

0.93

ALT > 34 U/L

2 (25%)

10 (22.72%)

0.88

LDH (U/L), highest measuredf

588.5 (447—892)

526 (350—1288)

0.65

LDH > 600 U/L

3 (50%)

17 40.47%)

0.65

CRP (mg/dL), highest measuredg

16.5

9.25 (1.43—21.72)

0.50

Creatinine (mg/dL), highest measured)h

0.58 (0.52–0.85)

0.52 (0.37–0.85)

0.07

  1. Values are presented as median (range) for continuous variables and as n(%) for categorical variables
  2. Abbreviations: WBC White blood cells, INR International normalized ratio, AST Aspartate aminotransferase, ALT Alanine aminotransferase, LDH Lactate dehydrogenase, CRP C-reactive protein
  3. a Complete blood count data were available for only 56 women in the recovered group
  4. b Data were available for 9 women in the recovered group and 42 women in the active- infection group
  5. c Data were available for 18 women in the recovered group and 72 women in the active- infection group
  6. d Data were available for 6 women in the recovered group and 43 in the active-infection group
  7. e Data were available for 8 patients in the recovered group and 44 in the active-infection group
  8. f Data were available for 6 women in the recovered group and 42 in the active-infection group
  9. g Data were available for one woman on the recovered group and 12 women in the active- infection group
  10. h Data were available for 7 women in the recovered group and 45 in the active-infection group